This is the authors' abstract. We don't add key points for this paper.
Focal nodular hyperplasia (FNH) is a regenerative volumetric liver formation that can occur as a result of the reaction of hepatocytes to local vascular circulatory disorders and is one of the late complications in patients who received high-dose chemotherapy followed by hematopoietic stem cell transplantation. This article presents a description of two clinical cases of development of liver FNH in patients with high-risk neuroblastoma identified in the late stages from the end of specific treatment. A possible reason for the development of liver FNH in these patients could be the use of alkylating drugs (ifosfamide, threosulfan, busulfan, melphalan).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sagoyan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: